All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-C282 | Human anti-BMLF1 T cell receptor (CB-C022), pCDTCR1 | EBV | CB-C022 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C283 | Human anti-BMLF1 T cell receptor (CB-C023), pCDTCR1 | EBV | CB-C023 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C284 | Human anti-BMLF1 T cell receptor (CB-C024), pCDTCR1 | EBV | CB-C024 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C285 | Human anti-BMLF1 T cell receptor (CB-C025), pCDTCR1 | EBV | CB-C025 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C286 | Human anti-BMLF1 T cell receptor (CB-C026), pCDTCR1 | EBV | CB-C026 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C287 | Human anti-BMLF1 T cell receptor (CB-C027), pCDTCR1 | EBV | CB-C027 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C288 | Human anti-BMLF1 T cell receptor (CB-C028), pCDTCR1 | EBV | CB-C028 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C289 | Human anti-BMLF1 T cell receptor (CB-C029), pCDTCR1 | EBV | CB-C029 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C290 | Human anti-BMLF1 T cell receptor (CB-C030), pCDTCR1 | EBV | CB-C030 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C291 | Human anti-BMLF1 T cell receptor (CB-C031), pCDTCR1 | EBV | CB-C031 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C292 | Human anti-BMLF1 T cell receptor (CB-C032), pCDTCR1 | EBV | CB-C032 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C293 | Human anti-BMLF1 T cell receptor (CB-C033), pCDTCR1 | EBV | CB-C033 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C294 | Human anti-BMLF1 T cell receptor (CB-C034), pCDTCR1 | EBV | CB-C034 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C295 | Human anti-BMLF1 T cell receptor (CB-C035), pCDTCR1 | EBV | CB-C035 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C296 | Human anti-BMLF1 T cell receptor (CB-C036), pCDTCR1 | EBV | CB-C036 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-C297 | Human anti-BMLF1 T cell receptor (CB-C037), pCDTCR1 | EBV | CB-C037 | Human | GLCTLVAML | HLA-A*02 | Lentiviral vector | |
TCR-ZP094 | Human anti-BMLF1 T cell receptor (AS01), pCDTCR1 | EBV | AS01 | Human | GLCTLVAML | HLA-A2 | Lentiviral vector | |
TCR-ZP095 | Human anti-BMLF1 T cell receptor (AM28), pCDTCR1 | EBV | AM28 | Human | GLCTLVAML | HLA-A2 | Lentiviral vector | |
TCR-ZP096 | Human anti-BMLF1 T cell receptor (KEL-13), pCDTCR1 | EBV | KEL-13 | Human | GLCTLVAML | HLA-A2 | Lentiviral vector | |
TCR-ZP097 | Human anti-BMLF1 T cell receptor ( AV), pCDTCR1 | EBV | AV | Human | GLCTLVAML | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION